Skip to main content
December 8, 2024
News
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
News
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Metastatic Breast Cancer Treatment
Triple Negative Breast Cancer
Truqap (capivasertib) in Breast Cancer
By Dr. C.H. Weaver M.D.
Nov 17, 2023
Breast Cancer Treatment
The FDA Approves Trodelvy (sacituzumab govitecan) for Recurrent HR+/HER2– Metastatic Breast Cancer
By Dr. C.H. Weaver M.D.
Feb 4, 2023
Breast Cancer Treatment
Personalized Immunotherapy With TILS for Advanced Breast Cancer.
By Dr. C.H. Weaver M.D.
Feb 3, 2022
Breast Cancer Treatment
PARP Inhibitors improve outcomes in BRCA mutated breast cancer. FDA approves Lynparza for treatment of TNBC and early stage breast cancer.
By Dr. C.H. Weaver M.D.
Jun 1, 2023
Breast Cancer Treatment
Ibrance Precision Cancer Medicine for Hormone Receptor Positive Breast Cancer
By Dr. C.H. Weaver M.D.
Jun 3, 2021
Breast Cancer Treatment
Kisqali Improves Survival in ER+ Advanced Breast Cancer
By Dr. C.H. Weaver M.D.
Dec 8, 2023
Breast Cancer Treatment
Enhertu (Trastuzumab Deruxtecan) Treatment of HER2+ Breast Cancer
By Dr. C.H. Weaver M.D.
Apr 13, 2023
Breast Cancer Overviews
Treatment of Stage IV - Metastatic Breast Cancer
By Dr. C.H. Weaver M.D.
Dec 24, 2022
Breast Cancer Treatment
Tukysa (tucatinib) – HER2 Inhibitor for Treatment of Breast Cancer
By Dr. C.H. Weaver M.D.
Dec 8, 2023
Breast Cancer Treatment
Abraxane™ Highly Effective in Metastatic Breast Cancer
By CancerConnect
Dec 24, 2022
Breast Cancer Treatment
Fatigue Common Among Long-Term Survivors of Breast Cancer
By Dr. C.H. Weaver M.D.
Mar 9, 2023
CLOSE
CLOSE
CLOSE
CLOSE